AR and posterior cortical atrophy: The therapeutic strategies of PCa treatment have been developed to target AR via a blockade of AR nuclear translocation [27,28], silencing of AR gene expression [8,29,30], including the full length or splice variants of AR, or interruption of the interaction between AR and its co-factors, as well as their downstream functions [27,28,31].